Mazumdar Claire 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Mazumdar Claire（CIK 2034671）在 1 家公司共报告 36 笔 SEC Form 4 内部人交易（最近一笔 2026-08-12）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 10,000 | $37,898 |
| 2026-08-12 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 10,000 | $279,750 |
| 2026-07-14 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 10,000 | $37,898 |
| 2026-07-14 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 9,972 | $283,367 |
| 2026-07-14 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 28 | $831 |
| 2026-05-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 15,000 | $56,850 |
| 2026-05-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 12,022 | $239,959 |
| 2026-05-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 2,978 | $60,602 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 15,000 | $354,150 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 7,454 | $28,251 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 7,080 | $38,586 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 15,000 | $56,850 |
| 2026-04-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 8,226 | $36,523 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 6,499 | $24,631 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 6,499 | $122,441 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 6,905 | $26,170 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 6,905 | $129,676 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 1,596 | $6,049 |
| 2026-03-20 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 1,596 | $30,244 |
| 2026-03-11 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 36,766 | $139,343 |
| 2026-03-11 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 36,766 | $704,804 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 2,631 | $9,971 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 2,631 | $49,279 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 买入 | 1,786 | $6,769 |
| 2026-03-06 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | 卖出 | 1,786 | $33,470 |
来源：SEC Form 4 申报文件 · 截至 2026-08-12